Breaking News Instant updates and real-time market news.

BLDP

Ballard Power

$3.14

-0.03 (-0.95%)

, HDSN

Hudson Technologies

$2.52

-0.095 (-3.63%)

04:55
05/16/18
05/16
04:55
05/16/18
04:55

Oppenheimer to hold a conference

3rd Annual Emerging Growth Conference will be held in New York on May 15-16.

BLDP

Ballard Power

$3.14

-0.03 (-0.95%)

HDSN

Hudson Technologies

$2.52

-0.095 (-3.63%)

TEUM

Pareteum

$2.38

-0.09 (-3.64%)

CPST

Capstone Turbine

$1.40

0.05 (3.70%)

BWEN

Broadwind Energy

$2.53

0.09 (3.69%)

FTNW

FTE Networks

$15.39

-1.01 (-6.16%)

DAIO

Data I/O

$7.14

-0.21 (-2.86%)

AKTS

Akoustis

$6.68

-0.25 (-3.61%)

APPS

Digital Turbine

$1.58

-0.04 (-2.47%)

AMRS

Amyris

$6.04

-0.14 (-2.27%)

LFGR

Leaf Group

$9.80

(0.00%)

  • 29

    May

  • 07

    Jun

  • 12

    Jun

  • 25

    Jun

BLDP Ballard Power
$3.14

-0.03 (-0.95%)

02/02/18
ADAM
02/02/18
NO CHANGE
Target $5
ADAM
Buy
Plug Power volatility obscures opportunity, says Canaccord
Canaccord analyst John Quealy noted Plug Power (PLUG) shares have pulled back recently but he is staying constructive on the longer-term opportunity taking shape. He believes the weakness could be in part due to a short report on Ballard Power (BLDP), but he believes that was more China related. Quealy reiterated his Buy rating and $5 price target on Plug Power shares.
09/18/17
09/18/17
NO CHANGE
Target $6

Buy
FBR boosts Ballard Power target to $6 after analyst day
FBR Capital analyst Carter Driscoll raised his price target for Ballard Power Systems to $6.00 from $3.50 saying the company's analyst day highlighted its "robust" China mobility opportunity. Ballard is the early stages of capitalizing on the use of fuel cells for vehicle electrification, and deserves to trade at a premium to peers given its technology leadership, local presence and partnerships in China and improving financial position, Driscoll tells investors in a research note partially tiled "A Vastly Different Company than Two Years Ago." The analyst reiterates a Buy rating on Ballard.
09/15/17
HCWC
09/15/17
NO CHANGE
Target $6
HCWC
Buy
H.C. Wainwright doubles price target on Ballard Power to $6
H.C. Wainwright analyst Amit Dayal doubled his price target on Ballard Power Systems to $6 from $3 citing his expectations for order book growth, increased certainty of execution in China, acceleration towards profitability and favorable macro trends. The analyst found the company's analyst day tone bullish. He maintains a Buy rating on the shares.
HDSN Hudson Technologies
$2.52

-0.095 (-3.63%)

08/10/17
CHLM
08/10/17
NO CHANGE
Target $10
CHLM
Buy
Hudson Tech acquisition of Airgas-Refrigerants a game changer, says Craig-Hallum
Craig-Hallum analyst Steven Dyer notes that Hudson Technologies (HDSN) delivered "solid" quarterly results and announced a transformative acquisition of Airgas-Refrigerants, a subsidiary of Airgas (ARG). The analyst believes the addition of Airgas will double Hudson Technologies' annual revenue and importantly adds scale, enhances the geographic footprint and customer base, and is expected to be "highly accretive" over time. Given its comparable size and myriad financial and competitive benefits, Dyer believes it could be "a game changer." He reiterates a Buy rating and $10 price target on Hudson Technologies' shares.
08/11/17
RILY
08/11/17
DOWNGRADE
Target $10
RILY
Neutral
Hudson Technologies downgraded to Neutral from Buy at B. Riley
B. Riley analyst Sarkis Sherbetchyan downgraded Hudson Technologies to Neutral saying the shares are fairly priced following the company's Q2 report. The analyst raised his price target for the stock to $10 from $8.50.
08/11/17
08/11/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Blue Apron (APRN) was downgraded to Hold from Buy at SunTrust, to Neutral from Buy at Citi, and to Perform from Outperform at Oppenheimer. 2. Snap (SNAP) downgraded to Neutral from Buy at Monness Crespi. 3. Navios Acquisition (NNA) downgraded to Neutral from Buy at Citi with analyst Christian Wetherbee saying he is becoming more concerned about the sustainability of the company's dividend with existing charters rolling off in the coming four quarters, following the company's quarterly results. 4. Masonite (DOOR) downgraded to Hold from Buy at Stifel with analyst John Baugh saying Wednesday night's results marked the second consecutive quarter of disappointment on the top and bottom lines. 5. Hudson Technologies (HDSN) downgraded to Neutral from Buy at B. Riley with analyst Sarkis Sherbetchyan saying the shares are fairly priced following the company's second quarter report. The analyst raised his price target for the stock to $10 from $8.50. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/22/17
ROTH
09/22/17
NO CHANGE
Target $11
ROTH
Buy
Roth says Hudson Technologies short report 'misconstrues' several points
Roth Capital analyst Gerry Sweeney attributes a negative Seeking Alpha article as the cause for Hudson Technologies' slide yesterday, but he believes the report touches upon items that have previously been highlighted and "misconstrues" several aspects of the company's story. Sweeney, who said "mixed gas" is a known aspect within the industry and players are positioned to manage the issue, keeps a Buy rating and $11 price target on Hudson shares, which fell about 8.5% yesterday to close at $8.47.
TEUM Pareteum
$2.38

-0.09 (-3.64%)

CPST Capstone Turbine
$1.40

0.05 (3.70%)

10/04/17
OPCO
10/04/17
UPGRADE
OPCO
Outperform
Capstone Turbine upgraded to Outperform from Perform at Oppenheimer
09/18/17
ROTH
09/18/17
UPGRADE
Target $2
ROTH
Buy
Capstone Turbine upgraded to Buy from Neutral at Roth Capital
Roth Capital analyst Craig Irwin upgraded Capstone Turbine to Buy from Neutral and raised his price target on the shares to $2 from 65c, as he believes recent storm activity in the U.S. and the Caribbean should support rebounding revenue. The analyst sees precedents from Hurricane Sandy, where Capstone saw strong uptick in activity across the N.Y. metropolitan area, and $10M incremental demand over the next 18-24 months. With Florida, Texas, and the Caribbean affected by recent storms, Irwin estimates there could be as much as $30M incremental demand.
09/18/17
HCWC
09/18/17
NO CHANGE
HCWC
Buy
Capstone Turbine joint vernture should boost sales, says H.C. Wainwright
H.C. Wainwright analyst Amit Dayal said the Capstone Energy Finance joint venture will allow the company to target a larger potential customer base, and believes Capstone is positioned favorably and should be able to grow its market share in the growing market. Dayal maintained a Buy rating and $2 price target on shares.
10/04/17
10/04/17
UPGRADE
Target $2

Outperform
Capstone Turbine upgraded to Outperform at Oppenheimer
As previously reported, Oppenheimer analyst Colin Rusch upgraded Capstone Turbine to Outperform from Perform, with a $2 price target. The analyst believes the company has effectively rationalized its overhead while working through a difficult period for demand. At the same time, with revenue approaching $100M annually, the shares are trading at an enterprise value of $24M including $10M in net cash, he adds. Rusch anticipates order activity to pick up and estimates the company will reach EBITDA break-even in FY19 as that order activity translates into sales growth.
BWEN Broadwind Energy
$2.53

0.09 (3.69%)

12/06/17
ROTH
12/06/17
NO CHANGE
ROTH
Tax bill could put 'BEAT' down on U.S. renewables, says Roth Capital
Roth Capital analyst Philip Shen believes the Senate Tax Cuts and Jobs Act includes multiple elements that could negatively affect renewable tax equity capacity, such as a cut in the corporate rate from 35% to 20%, the passage of the Base Erosion Anti-Abuse Tax, or BEAT, without exemptions for solar/wind credits, and a reduction in the number of years the product tax credit could be claimed from 10 down to four years. Near-term, the analyst believes that continued negotiations on the Hill could cause increased volatility for his universe of stocks with direct or indirect exposure to the U.S. solar and wind markets, such as AMSC (AMSC), Broadwind Energy (BWEN), 8point3 Energy (CAFD), Canadian Solar (CSIQ), Daqo New Energy (DQ), Enphase Energy (ENPH), First Solar (FSLR), Hannon Armstrong (HASI), Hanwah Q CELLS (HQCL), JA Solar (JASO), JinkoSolar (JKS), SolarEdge (SEDG), Sky Solar (SKYS), ReneSola (SOL), Sunworks (SUNW), and TPI Composites (TPIC).
FTNW FTE Networks
$15.39

-1.01 (-6.16%)

DAIO Data I/O
$7.14

-0.21 (-2.86%)

04/06/18
LSCM
04/06/18
NO CHANGE
Target $13
LSCM
Buy
Data I/O selloff brings attractive entry point, says Lake Street
Lake Street analyst Jaeson Schmidt believes the selloff in Data I/O shares since the company's Q4 results in late February creates an attractive entry point. After hosting investor meetings with management, the analyst reiterates a Buy rating on the shares with a $13 price target. Data I/O's exposure to "attractive secular growth trends and strong margin profile offer a compelling story," the analyst tells investors in a research note.
02/07/18
02/07/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. HP Inc. (HPQ) was initiated with a Neutral at Goldman Sachs, while Cisco (CSCO) was initiated with a Buy. 2. Tronox (TROX) initiated with an Outperform at Wells Fargo. 3. Data I/O (DAIO) initiated with a Buy at RF Lafferty. 4. SailPoint Technologies (SAIL) initiated with a Buy at Needham. 5. Aimmune (AIMT) initiated with an Outperform at RBC Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/07/18
RFLF
02/07/18
INITIATION
Target $15
RFLF
Buy
Data I/O initiated with a Buy at RF Lafferty
RF Lafferty analyst James Anderson initiated Data I/O with a Buy and $15 price target.
04/27/18
LSCM
04/27/18
NO CHANGE
Target $9
LSCM
Buy
Data I/O price target lowered to $9 from $13 at Lake Street
Lake Street analyst Jaeson Schmidt lowered his price target for Data I/O to $9 after the company reported an earnings miss for Q1. The analyst views the quarter as mixed with investments to fuel future growth eating into near-term profitability. He maintains a Buy rating on the shares.
AKTS Akoustis
$6.68

-0.25 (-3.61%)

APPS Digital Turbine
$1.58

-0.04 (-2.47%)

04/26/18
RILY
04/26/18
NO CHANGE
Target $2.8
RILY
Buy
Digital Turbine pullback brings buying opportunity, says B. Riley FBR
B. Riley FBR analyst Sameet Sinha views the recent pullback in shares of Digital Turbine as a buying opportunity. The analyst sees several catalysts ahead and reiterates a Buy rating on the shares with a $2.80 price target.
03/27/18
RILY
03/27/18
NO CHANGE
Target $2.8
RILY
Buy
Digital Turbine should be bought on Facebook-related pullback, says B. Riley FBR
B. Riley FBR analyst Sameet Sinha recommends buying shares of Digital Turbine (APPS) following the recent 16% pullback in the shares. The analyst believes the selloff is likely caused by Facebook's (FB) alleged data misuse. Digital Turbine creates data vaults between carriers and partners, and "hence is actually aiding privacy initiatives," Sinha tells investors in a research note. The analyst keeps a Buy rating on the shares with a $2.80 price target.
AMRS Amyris
$6.04

-0.14 (-2.27%)

03/20/18
RILY
03/20/18
NO CHANGE
Target $10
RILY
Buy
Amyris price target raised to $10 from $8 at B. Riley FBR
B. Riley FBR analyst Carter Driscoll raised his price target for Amyris to $10 and added the shares to his firm's Alpha Generator list. The analyst expects the commercial sweetener market to drive a back-half loaded year and positive earnings in 2019. Further, self-funding 2018 operations should quiet liquidity concerns, Driscoll tells investors in a research note. He keeps a Buy rating on Amyris.
01/25/18
01/25/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. At Home Group (HOME) initiated with an Overweight at Barclays. 2. Amyris (AMRS) initiated with a Buy at B. Riley FBR. 3. Eagle Bulk Shipping (EGLE) initiated with a Buy at Deutsche Bank. 4. Flex Pharma (FLKS) initiated with a Buy at Ladenburg. 5. CME Group (CME) initiated with a Hold at Berenberg. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/25/18
RILY
01/25/18
INITIATION
Target $8
RILY
Buy
Amyris initiated with a Buy at B. Riley FBR
B. Riley FBR analyst Carter Driscoll started Amyris with a Buy rating and $8 price target. The analyst views the company as a "unique" given its synthetic biology creating sustainable materials and feedstocks. He finds the stock attractively valued at current levels.
LFGR Leaf Group
$9.80

(0.00%)

06/16/17
CHLM
06/16/17
NO CHANGE
Target $12
CHLM
Buy
comScore traffic data encouraging for Leaf Group, says Craig-Hallum
Craig-Hallum analyst Jason Kreyer noted that comScore traffic data points to Leaf Group's continued progress towards stabilizing and growing key properties, such as its eHow portfolio. Kreyer keeps a Buy rating and $12 price target on Leaf Group shares.

TODAY'S FREE FLY STORIES

HDNG

Hardinge

$18.44

0.03 (0.16%)

15:35
05/20/18
05/20
15:35
05/20/18
15:35
Conference/Events
Hardinge to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBRG

Bravo Brio Restaurant

$4.05

(0.00%)

15:30
05/20/18
05/20
15:30
05/20/18
15:30
Conference/Events
Bravo Brio Restaurant to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAYRY

Bayer

$0.00

(0.00%)

, BDX

Becton Dickinson

$225.01

0.81 (0.36%)

04:55
05/20/18
05/20
04:55
05/20/18
04:55
Conference/Events
American Thoracic Society to hold a conference »

ATS 2018 will be held in…

BAYRY

Bayer

$0.00

(0.00%)

BDX

Becton Dickinson

$225.01

0.81 (0.36%)

BIIB

Biogen

$280.35

-0.34 (-0.12%)

BSX

Boston Scientific

$30.46

0.13 (0.43%)

CELG

Celgene

$78.39

-1.59 (-1.99%)

DNA

Bought by RHHBY

$0.00

(0.00%)

FGEN

FibroGen

$51.10

-0.2 (-0.39%)

GSK

GlaxoSmithKline

$40.04

-0.06 (-0.15%)

HRC

Hill-Rom

$90.58

0.86 (0.96%)

INNV

Innovus Pharmaceuticals

$0.00

(0.00%)

RETA

Reata Pharmaceuticals

$31.58

-0.59 (-1.83%)

OCX

OncoCyte

$2.55

0.05 (2.00%)

VVUS

VIVUS

$0.79

0.1672 (26.78%)

NBRV

Nabriva Therapeutics

$5.43

0.25 (4.83%)

MYL

Mylan

$39.65

-0.45 (-1.12%)

MASI

Masimo

$97.11

0.34 (0.35%)

TEVA

Teva

$21.23

0.12 (0.57%)

STEM

Ticker changed to MBOT

$0.00

(0.00%)

JAZZ

Jazz Pharmaceuticals

$167.60

2.55 (1.55%)

REGN

Regeneron

$301.87

-6.26 (-2.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 21

    May

  • 21

    May

  • 24

    May

  • 30

    May

  • 31

    May

  • 03

    Jun

  • 05

    Jun

  • 05

    Jun

  • 13

    Jun

  • 13

    Jun

  • 14

    Jun

  • 16

    Jun

  • 25

    Jun

  • 26

    Jun

  • 11

    Aug

  • 07

    Sep

  • 20

    Oct

  • 13

    Nov

  • 20

    Dec

CBS

CBS

$51.75

0.14 (0.27%)

, VIA

Viacom

$33.80

-0.75 (-2.17%)

13:23
05/19/18
05/19
13:23
05/19/18
13:23
Periodicals
CBS looks like a bargain, Barron's says »

In a follow-up story,…

CBS

CBS

$51.75

0.14 (0.27%)

VIA

Viacom

$33.80

-0.75 (-2.17%)

VIAB

Viacom

$27.24

-0.92 (-3.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$73.45

-0.51 (-0.69%)

, PEP

PepsiCo

$97.51

-0.45 (-0.46%)

13:10
05/19/18
05/19
13:10
05/19/18
13:10
Periodicals
Coca-Cola, PepsiCo look like bargains, Barron's says »

Investors have punished…

PG

Procter & Gamble

$73.45

-0.51 (-0.69%)

PEP

PepsiCo

$97.51

-0.45 (-0.46%)

KO

Coca-Cola

$42.18

-0.13 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROKU

Roku

$35.40

1.14 (3.33%)

10:32
05/19/18
05/19
10:32
05/19/18
10:32
Periodicals
Roku relevance worth taking note of, Barron's says »

Roku now is mostly a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

LOW

Lowe's

$86.31

0.85 (0.99%)

10:19
05/19/18
05/19
10:19
05/19/18
10:19
Periodicals
Lowe's turnaround what matters for long-term investors, Barron's says »

With Lowe's shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

AAPL

Apple

$186.31

-0.69 (-0.37%)

, ZTCOY

ZTE Corp.

$0.00

(0.00%)

08:41
05/19/18
05/19
08:41
05/19/18
08:41
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$186.31

-0.69 (-0.37%)

ZTCOY

ZTE Corp.

$0.00

(0.00%)

ACIA

Acacia Communications

$32.97

0.45 (1.38%)

OCLR

Oclaro

$8.88

-0.015 (-0.17%)

TOSBF

Toshiba, also use TOSYY

$0.00

(0.00%)

TOSYY

Toshiba, also use TOSBF

$0.00

(0.00%)

GM

General Motors

$37.80

-0.51 (-1.33%)

F

Ford

$11.33

-0.12 (-1.05%)

FCAU

Fiat Chrysler

$21.86

-0.31 (-1.40%)

HMC

Honda

$32.98

-0.11 (-0.33%)

TM

Toyota

$136.04

-0.54 (-0.40%)

NSANY

Nissan

$0.00

(0.00%)

VLKAY

Volkswagen

$0.00

(0.00%)

DDAIF

Daimler AG

$0.00

(0.00%)

VRX

Valeant

$22.15

0.12 (0.54%)

PFE

Pfizer

$35.64

-0.07 (-0.20%)

BIIB

Biogen

$280.35

-0.34 (-0.12%)

INSY

Insys Therapeutics

$6.95

-0.37 (-5.05%)

VVUS

VIVUS

$0.79

0.1672 (26.78%)

CELG

Celgene

$78.39

-1.59 (-1.99%)

BAYRY

Bayer

$0.00

(0.00%)

GILD

Gilead

$68.01

0.41 (0.61%)

BMRN

BioMarin

$88.95

0.51 (0.58%)

MNK

Mallinckrodt

$15.70

-0.37 (-2.30%)

SHPG

Shire

$169.62

-2.18 (-1.27%)

MRK

Merck

$59.13

0.06 (0.10%)

JAZZ

Jazz Pharmaceuticals

$167.60

2.55 (1.55%)

TEVA

Teva

$21.23

0.12 (0.57%)

AZN

AstraZeneca

$36.34

-0.09 (-0.25%)

ACOR

Acorda Therapeutics

$23.65

-0.45 (-1.87%)

MYL

Mylan

$39.65

-0.45 (-1.12%)

NVS

Novartis

$77.08

-0.07 (-0.09%)

RHHBY

Roche

$0.00

(0.00%)

GALE

Galena

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 21

    May

  • 21

    May

  • 22

    May

  • 24

    May

  • 25

    May

  • 29

    May

  • 30

    May

  • 30

    May

  • 31

    May

  • 03

    Jun

  • 04

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 12

    Jun

  • 13

    Jun

  • 13

    Jun

  • 14

    Jun

  • 16

    Jun

  • 18

    Jun

  • 19

    Jun

  • 20

    Jun

  • 22

    Aug

  • 27

    Aug

  • 07

    Sep

  • 10

    Sep

  • 12

    Sep

  • 05

    Oct

  • 23

    Oct

  • 13

    Nov

  • 20

    Dec

  • 21

    Dec

BAYRY

Bayer

$0.00

(0.00%)

, BDX

Becton Dickinson

$225.01

0.81 (0.36%)

04:55
05/19/18
05/19
04:55
05/19/18
04:55
Conference/Events
American Thoracic Society to hold a conference »

ATS 2018 will be held in…

BAYRY

Bayer

$0.00

(0.00%)

BDX

Becton Dickinson

$225.01

0.81 (0.36%)

BIIB

Biogen

$280.35

-0.34 (-0.12%)

BSX

Boston Scientific

$30.46

0.13 (0.43%)

CELG

Celgene

$78.39

-1.59 (-1.99%)

DNA

Bought by RHHBY

$0.00

(0.00%)

FGEN

FibroGen

$51.10

-0.2 (-0.39%)

GSK

GlaxoSmithKline

$40.04

-0.06 (-0.15%)

HRC

Hill-Rom

$90.58

0.86 (0.96%)

INNV

Innovus Pharmaceuticals

$0.00

(0.00%)

RETA

Reata Pharmaceuticals

$31.58

-0.59 (-1.83%)

OCX

OncoCyte

$2.55

0.05 (2.00%)

VVUS

VIVUS

$0.79

0.1672 (26.78%)

NBRV

Nabriva Therapeutics

$5.43

0.25 (4.83%)

MYL

Mylan

$39.65

-0.45 (-1.12%)

MASI

Masimo

$97.11

0.34 (0.35%)

TEVA

Teva

$21.23

0.12 (0.57%)

STEM

Ticker changed to MBOT

$0.00

(0.00%)

JAZZ

Jazz Pharmaceuticals

$167.60

2.55 (1.55%)

REGN

Regeneron

$301.87

-6.26 (-2.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 21

    May

  • 21

    May

  • 24

    May

  • 30

    May

  • 31

    May

  • 03

    Jun

  • 05

    Jun

  • 13

    Jun

  • 13

    Jun

  • 14

    Jun

  • 16

    Jun

  • 25

    Jun

  • 26

    Jun

  • 11

    Aug

  • 07

    Sep

  • 20

    Oct

  • 13

    Nov

  • 20

    Dec

SLDB

Solid Biosciences

$21.96

-0.79 (-3.47%)

18:46
05/18/18
05/18
18:46
05/18/18
18:46
Hot Stocks
Solid Biosciences announces new preclinical data for SGT-001 »

Solid Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$271.35

-0.66 (-0.24%)

, USO

United States Oil Fund

$14.43

-0.06 (-0.41%)

18:04
05/18/18
05/18
18:04
05/18/18
18:04
General news
Weekly CFTC Commitment of Traders highlights »

S&P500 net long 2.4K…

SPY

SPDR S&P 500 ETF Trust

$271.35

-0.66 (-0.24%)

USO

United States Oil Fund

$14.43

-0.06 (-0.41%)

GLD

SPDR Gold Trust

$122.42

0.06 (0.05%)

FXE

Euro Currency Trust

$113.01

-0.28 (-0.25%)

FXC

CurrencyShares Canadian Dollar Trust

$76.61

-0.38 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$114.04

0.11 (0.10%)

18:02
05/18/18
05/18
18:02
05/18/18
18:02
Hot Stocks
Celanese raises prices for emulsion polymers and acetyls »

Celanese Corporation will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

JBHT

J.B. Hunt

$126.85

1.06 (0.84%)

18:01
05/18/18
05/18
18:01
05/18/18
18:01
Hot Stocks
J.B. Hunt director Garrison sells 100,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$36.34

-0.09 (-0.25%)

17:56
05/18/18
05/18
17:56
05/18/18
17:56
Hot Stocks
AstraZeneca confirms FDA approval of Lokelma »

AstraZeneca announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

XLE

Energy Select Sector SPDR

$78.11

-0.62 (-0.79%)

, XLU

Utilities SPDR

$48.97

-0.02 (-0.04%)

17:48
05/18/18
05/18
17:48
05/18/18
17:48
General news
Week ending ETF Scorecard: Energy rallies while Utilities and Real Estate slide »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$78.11

-0.62 (-0.79%)

XLU

Utilities SPDR

$48.97

-0.02 (-0.04%)

IYR

DJ US Real Estate Index Fund

$75.47

0.15 (0.20%)

XLP

Consumer Staples Sector SPDR

$49.53

-0.33 (-0.66%)

XLY

Consumer Discretionary Sector SPDR

$104.87

-0.12 (-0.11%)

XLB

S&P Select Materials SPDR

$59.87

0.09 (0.15%)

XLF

Financial Select Sector

$27.95

-0.255 (-0.90%)

XLV

Health Care Select Sector SPDR

$83.23

0.24 (0.29%)

XLK

Technology Select Sector SPDR

$68.89

-0.28 (-0.40%)

XLI

Industrial Select Sector SPDR

$75.34

0.45 (0.60%)

GLD

SPDR Gold Trust

$122.42

0.06 (0.05%)

SLV

iShares Silver Trust

$15.48

-0.005 (-0.03%)

USO

United States Oil Fund

$14.43

-0.06 (-0.41%)

UNG

United States Natural Gas Fund

$23.19

-0.085 (-0.37%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$85.38

-0.095 (-0.11%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$114.28

0.475 (0.42%)

TLT

iShares 20+ Year Treasury Bond Fund

$117.21

0.98 (0.84%)

IEF

iShares 7-10 Year Treasury Bond ETF

$100.76

0.4 (0.40%)

SHY

iShares 1-3 Year Treasury Bond

$83.18

0.05 (0.06%)

IWD

iShares Russell 1000 Value

$122.33

-0.49 (-0.40%)

IWF

iShares Russell 1000 Growth

$141.58

-0.03 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATHN

athenahealth

$150.09

0.64 (0.43%)

17:37
05/18/18
05/18
17:37
05/18/18
17:37
Hot Stocks
Janus Henderson reports 11.9% stake in athenahealth, urges for sale process »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 06

    Jun

YGYI

Youngevity International

$3.90

-0.08 (-2.01%)

17:33
05/18/18
05/18
17:33
05/18/18
17:33
Syndicate
Breaking Syndicate news story on Youngevity International »

Youngevity International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZTCOY

ZTE Corp.

$0.00

(0.00%)

17:32
05/18/18
05/18
17:32
05/18/18
17:32
Periodicals
Kudlow: ZTE needs to overhaul management to get U.S. reprieve, Bloomberg says »

White House National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PF

Pinnacle Foods

$63.23

-0.45 (-0.71%)

, CAG

Conagra Brands

$37.43

-0.28 (-0.74%)

17:31
05/18/18
05/18
17:31
05/18/18
17:31
Periodicals
Pinnacle Foods hires Evercore Partners to examine alternatives, NY Post says »

Pinnacle Foods (PF) has…

PF

Pinnacle Foods

$63.23

-0.45 (-0.71%)

CAG

Conagra Brands

$37.43

-0.28 (-0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

MYND

MYnd Analytics

$3.28

0.075 (2.34%)

17:25
05/18/18
05/18
17:25
05/18/18
17:25
Syndicate
Breaking Syndicate news story on MYnd Analytics »

MYnd Analytics files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INWK

InnerWorkings

$8.71

-0.08 (-0.91%)

17:16
05/18/18
05/18
17:16
05/18/18
17:16
Hot Stocks
InnerWorkings receives Nasdaq non-compliance letter due to late 10-Q filing »

InnerWorkings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

ADMA

ADMA Biologics

$5.46

0.05 (0.92%)

17:05
05/18/18
05/18
17:05
05/18/18
17:05
Syndicate
Breaking Syndicate news story on ADMA Biologics »

ADMA Biologics files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADMA

ADMA Biologics

$5.46

0.05 (0.92%)

17:05
05/18/18
05/18
17:05
05/18/18
17:05
Syndicate
Breaking Syndicate news story on ADMA Biologics »

ADMA Biologics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLDB

Solid Biosciences

$21.96

-0.79 (-3.47%)

17:04
05/18/18
05/18
17:04
05/18/18
17:04
Hot Stocks
Breaking Hot Stocks news story on Solid Biosciences »

Boxer Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EDIT

Editas Medicine

$34.85

-3.14 (-8.27%)

17:03
05/18/18
05/18
17:03
05/18/18
17:03
Hot Stocks
Editas Medicine data shows subretinal EDIT-101 injection tolerated in primates »

Editas Medicine announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.